METASTATIC PRIMARY CENTRAL CHONDROSARCOMA
Clinical trials for METASTATIC PRIMARY CENTRAL CHONDROSARCOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PRIMARY CENTRAL CHONDROSARCOMA trials appear
Sign up with your email to follow new studies for METASTATIC PRIMARY CENTRAL CHONDROSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise for rare bone cancer
Disease control OngoingThis study tests two drug combinations (belinostat plus guadecitabine or ASTX727) in 19 adults with a rare bone cancer called chondrosarcoma that cannot be surgically removed or has spread. The goal is to see if the drugs can shrink tumors or stop them from growing. Participants …
Matched conditions: METASTATIC PRIMARY CENTRAL CHONDROSARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 10:34 UTC
-
Immunotherapy drug shows promise for rare sarcomas in early trial
Disease control OngoingThis study tested the drug atezolizumab in 27 people with rare cancers called chondrosarcoma and clear cell sarcoma that could not be removed by surgery or had spread. The drug helps the body's immune system attack cancer cells. The main goal was to see if tumors shrank or stoppe…
Matched conditions: METASTATIC PRIMARY CENTRAL CHONDROSARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 10:28 UTC